The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Forsyth Douglas since 2007.
This trader's CIK number is 1240801.
At the time of last reporting, Forsyth Douglas was the Director of Inhibrx Biosciences, Inc.. (stock ticker symbol INBX).
Also see all insider trading activities at Inhibrx Biosciences, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2014 | NCV | 0 | $0 | 15,000 | $158,640 | 0 | $0 |
| 2007 | NCV | 15,000 | $177,120 | 0 | $0 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2020 | NIE | 0 | $0 | 20,000 | $493,280 | 0 | $0 |
| 2008 | NIE | 10,000 | $150,090 | 0 | $0 | 0 | $0 |
| 2007 | NIE | 10,000 | $205,775 | 0 | $0 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2024 | INBX | 75,000 | $1,037,327 | 0 | $0 | 0 | $0 |
1. Virtus Allianzgi Convertible & Income Fund (NCV)
2. Virtus Equity & Convertible Income Fund (NIE)
3. Inhibrx Biosciences, Inc. (INBX)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2014-06-25 | NCV | Sale | 15,000 | 10.58 | 158,640 |
| 2007-08-15 | NCV | Buy | 15,000 | 11.81 | 177,120 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2020-08-11 | NIE | Sale | 20,000 | 24.66 | 493,280 |
| 2008-09-18 | NIE | Buy | 10,000 | 15.01 | 150,090 |
| 2007-08-17 | NIE | Buy | 5,000 | 21.59 | 107,965 |
| 2007-08-16 | NIE | Buy | 5,000 | 19.56 | 97,810 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2024-08-23 | INBX | Buy | 59,812 | 14.07 | 841,554 |
| 2024-08-22 | INBX | Buy | 15,188 | 12.89 | 195,773 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Forsyth Douglas (Director of Inhibrx Biosciences, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.